This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignee: Quantum-Si Incorporated. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Innovations of Mohammad Wadud Bhuiya in Polymerizing Enzymes
Introduction:
Mohammad Wadud Bhuiya is a notable inventor based in Olivette, MO, who has made significant contributions to the field of biochemistry through his innovative work with polymerizing enzymes. His advancements hold promise for enhancing nucleic acid sequencing and synthesis, which are crucial in various scientific and medical applications.
Latest Patents:
One of Bhuiya's key patents is focused on the development of compositions comprising modified recombinant polymerizing enzymes. This patent encompasses methods of using these enzymes for synthesizing nucleic acid molecules and for sequencing nucleic acid templates. This initiative not only emphasizes the importance of innovation in the field but also showcases Bhuiya's commitment to advancing biotechnological methods.
Career Highlights:
Currently, Mohammad Wadud Bhuiya contributes his expertise to Quantum-Si Incorporated, a company known for its pioneering work in the realm of next-generation sequencing technologies. His role within the company highlights his deep engagement in research and application of cutting-edge biotechnologies.
Collaborations:
Throughout his career, Bhuiya has collaborated with esteemed colleagues such as Brian Reed and Manjula Pandey. These professional associations have enabled a sharing of ideas and collaboration that further drives innovation and progress within their field.
Conclusion:
In summary, Mohammad Wadud Bhuiya is a distinguished inventor whose work on polymerizing enzymes is reshaping the landscape of nucleic acid sequencing. His patent contributions and collaborative efforts at Quantum-Si Incorporated reflect a commitment to scientific advancement and innovation in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
